Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

United States Antimony (UAMY) Gains from Sales and Divestitures (2025)

United States Antimony's Gains from Sales and Divestitures history spans 1 years, with the latest figure at $1.4 million for Q4 2025.

On a quarterly basis, Gains from Sales and Divestitures changed N/A to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a N/A change, with the full-year FY2025 number at $1.4 million, changed N/A from a year prior.
Gains from Sales and Divestitures hit $1.4 million in Q4 2025 for United States Antimony.
Over the last five years, Gains from Sales and Divestitures for UAMY hit a ceiling of $1.4 million in Q4 2025 and a floor of $1.4 million in Q4 2025.